Johns Hopkins University has joined a lawsuit against the National Institutes of Health (NIH) after a proposed policy to drastically cut funding for medical research. These cuts, aimed at reducing “indirect costs,” could halt critical research and delay life-saving medical advancements. The university, along with other leading institutions, is fighting to protect the future of healthcare breakthroughs.
Johns Hopkins University, renowned for its leadership in medical research, has joined forces with 12 other universities and national organizations to challenge the NIH’s recent decision to cap reimbursement for indirect costs at 15%. Indirect costs, which account for a significant portion of NIH grants, cover necessary expenses like facility maintenance, administrative support, and research infrastructure. This cap could result in over $4 billion in cuts across the nation's medical research institutions, putting countless vital studies at risk.
President Ron Daniels and CEO Theodore DeWeese highlighted in a message to the Hopkins community that these cuts would have an immediate and disastrous impact on the university’s extensive medical research, including nearly 600 ongoing clinical trials. These trials span various fields, from cancer research to pediatrics, and the new policy could disrupt not only groundbreaking work but also the care and hope they provide to patients.
At Johns Hopkins alone, NIH funding plays a crucial role in advancing medical knowledge and improving patient care. In fiscal year 2024, the university received over $1 billion in NIH research funding, with nearly a third of this covering indirect costs. These funds support essential aspects of research, such as laboratory facilities, equipment, and expert staff—all of which are necessary to conduct high-level scientific work.
The new policy would endanger hundreds of projects aimed at tackling some of the most pressing health issues, including cancer, heart disease, mental health, and aging. Without sufficient funding for indirect costs, crucial components of these studies would be compromised, potentially halting progress on life-saving treatments and cures.
Prominent faculty members like Professor Jack Iwashyna, who is researching faster recovery methods for pneumonia patients, would be directly impacted by the cuts. Iwashyna’s team relies on advanced computing systems to analyze millions of data points, essential for their study. Without funding for this technology, critical research would grind to a halt, delaying improvements in patient recovery times and increasing healthcare costs.
Similarly, Professor Otis Brawley’s work on cancer disparities in Maryland relies on data systems supported by NIH indirect funding. Cutting this support would halt his efforts to understand and address health inequalities, particularly in communities with high smoking rates, which could lead to a rise in smoking-related cancers in the coming decades.
Johns Hopkins University, along with its academic peers, remains committed to fighting for the preservation of federal funding for medical research. Daniels and DeWeese emphasized that these cuts pose a significant threat to not only the university’s research endeavors but also the broader American research ecosystem. As the NIH is the primary source of federal funding for medical research, the consequences of these cuts could reverberate across the nation, stalling advancements in healthcare and hindering progress in treating diseases.
In closing, the university’s leadership has pledged to continue advocating for the critical role of academic research and the necessary funding that supports it. As they work with national partners to challenge the NIH policy, they reaffirm their commitment to preserving the excellence and life-changing work of Johns Hopkins researchers.
Johns Hopkins University’s message is clear: these cuts threaten more than just funding—they jeopardize lives and the future of medical research. The university and its partners will continue to fight for the resources needed to push forward innovative discoveries and provide hope to patients worldwide.
Read more about this Challenge at Johns Hopkins ...